The KM analysis also demonstrated that high GJB3 expression was associated with a worse DSS (Figure 3A–3H) and PFI (Figure 4A–4H) of patients with Glioblastoma multiforme (GBM), KIRC, LUAD, MESO, and PAAD. Here, GJB3 is linked to pancreatic adenocarcinoma.